19 Unfortunately, the mechanism of GC therapy slowing cardiac disease remains unclear and is likely complex; in addition, GC type and dosing regimen are likely to be significant confounding variables.
← all excerpts
A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing Landscape.
1
—
—